Cargando…

Invisible spread of SARS-CoV-2 – Authors' reply

Detalles Bibliográficos
Autores principales:	Kucharski, Adam J, Eggo, Rosalind M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141466/ https://www.ncbi.nlm.nih.gov/pubmed/32275870 http://dx.doi.org/10.1016/S1473-3099(20)30275-9

Ejemplares similares

Secondary attack rate and superspreading events for SARS-CoV-2
por: Liu, Yang, et al.
Publicado: (2020)

Invisible spread of SARS-CoV-2
por: Xiong, Nian, et al.
Publicado: (2020)

The “Invisible Enemy” SARS-CoV-2: Viral Spread and Drug Treatment
por: Tanase, Alina, et al.
Publicado: (2022)

Feasibility of controlling COVID-19 – Authors' reply
por: Eggo, Rosalind M, et al.
Publicado: (2020)

SARS-CoV-2 shedding and infectivity – Authors' reply
por: Zhou, Fei, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain – Authors' reply
por: Pollán, Marina, et al.
Publicado: (2020)

On the fallibility of simulation models in informing pandemic responses – Authors' reply
por: Hellewell, Joel, et al.
Publicado: (2020)

SARS-CoV-2 infection in conjunctival tissue – Authors' reply
por: Hui, Kenrie PY, et al.
Publicado: (2020)

Neuropathology associated with SARS-CoV-2 infection – Authors' reply
por: von Weyhern, Claus Hann, et al.
Publicado: (2021)

The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship
por: Emery, Jon C, et al.
Publicado: (2020)

Stability of SARS-CoV-2 in different environmental conditions – Authors' reply
por: Chin, Alex W H, et al.
Publicado: (2020)

Practical measures for SARS-CoV-2 infection prevention – Authors' reply
por: Llibre, Josep M, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees – Authors' reply
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing – Authors' reply
por: Lohse, Stefan, et al.
Publicado: (2020)

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
por: Teng, Jialin, et al.
Publicado: (2021)

Transmission of SARS-CoV-2: still up in the air – Authors' reply
por: Greenhalgh, Trisha, et al.
Publicado: (2022)

SARS-CoV-2 rapid antigen detection tests – Authors' reply
por: Peeling, Rosanna W, et al.
Publicado: (2021)

Serological assays for delayed SARS-CoV-2 case identification – Author's reply
por: Pallett, Scott J C, et al.
Publicado: (2020)

Electron microscopy of SARS-CoV-2: a challenging task – Authors' reply
por: Varga, Zsuzsanna, et al.
Publicado: (2020)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals – Authors' reply
por: Lalvani, Ajit, et al.
Publicado: (2022)

Inhibiting Myopia by (Nearly) Invisible Light? - Author's Reply
por: Tsubota, Kazuo
Publicado: (2017)

Managing neonates with respiratory failure due to SARS-CoV-2 – Authors' reply
por: Wang, Jianhui, et al.
Publicado: (2020)

CT screening for early diagnosis of SARS-CoV-2 infection – Authors' reply
por: Shi, Heshui, et al.
Publicado: (2020)

Neutrophils as a pallbearer for SARS-CoV-2 disease burden – Authors’ reply
por: Lutter, René, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Unclear conclusions on SARS-CoV-2 elimination versus mitigation – Authors' reply
por: Oliu-Barton, Miquel, et al.
Publicado: (2021)

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story – Authors' reply
por: Ozonoff, Al, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
por: Alexander, James L, et al.
Publicado: (2021)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients—Authors´ Reply
por: Stumpf, Julian, et al.
Publicado: (2021)

Misclassification bias in estimating clinical severity of SARS-CoV-2 variants – Authors' reply
por: Nyberg, Tommy, et al.
Publicado: (2022)

The ability of the neonatal immune response to handle SARS-CoV-2 infection – Authors' reply
por: Gale, Chris, et al.
Publicado: (2021)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
por: Voysey, Merryn, et al.
Publicado: (2020)

Association of SARS-CoV-2 renal tropism with acute kidney injury – Authors' reply
por: Braun, Fabian, et al.
Publicado: (2020)

Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? – Authors' reply
por: Tsang, Nicole Ngai Yung, et al.
Publicado: (2021)

Author’s reply to the Letter to the Editor “The study of olfactory dysfunction in SARS-CoV-2 variants”
por: Hintschich, Constantin A., et al.
Publicado: (2022)

Concerns regarding risk factors for SARS-CoV-2 transmission to pets: author's reply
por: Alberto-Orlando, Solon, et al.
Publicado: (2023)

Expected Duration of Adverse Pregnancy Outcomes after Zika Epidemic
por: Eggo, Rosalind M., et al.
Publicado: (2018)

The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS-CoV-2 Percentage Positivity
por: Kovacevic, Aleksandra, et al.
Publicado: (2021)

On the temporal spreading of the SARS-CoV-2
por: Bertacchini, Francesca, et al.
Publicado: (2020)

Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK – Authors' reply
por: Black, James R M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t402jh0611af4imgjk848npei4